Literature DB >> 30557952

The American Society of Clinical Oncology-endorsed American Society for Radiation Oncology Evidence-Based Guideline of stereotactic body radiotherapy for early-stage non-small cell lung cancer: An expert opinion.

Matthias Guckenberger1, Joachim G Aerts2, Paul Van Schil3, Walter Weder4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30557952     DOI： 10.1016/j.jtcvs.2018.09.107

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN： 0022-5223            Impact factor:   5.209


× No keyword cloud information.
  3 in total

1.  Radiation-Induced Secondary Cancer Risk Assessment in Patients With Lung Cancer After Stereotactic Body Radiotherapy Using the CyberKnife M6 System With Lung-Optimized Treatment.

Authors:  Pei-Ju Chao; I-Hsing Tsai; Chun-Chieh Huang; Chih-Hsueh Lin; Chin-Shiuh Shieh; Yang-Wei Hsieh; Pei-Ying Yang; Hsiao-Fei Lee; Tsair-Fwu Lee
Journal:  Front Bioeng Biotechnol       Date:  2020-05-07

2.  Radiomics for prediction of radiation-induced lung injury and oncologic outcome after robotic stereotactic body radiotherapy of lung cancer: results from two independent institutions.

Authors:  Khaled Bousabarah; Oliver Blanck; Susanne Temming; Maria-Lisa Wilhelm; Mauritius Hoevels; Wolfgang W Baus; Daniel Ruess; Veerle Visser-Vandewalle; Maximilian I Ruge; Harald Treuer; Martin Kocher
Journal:  Radiat Oncol       Date:  2021-04-16       Impact factor: 3.481

Review 3.  Challenges and Suggestions in Management of Lung and Liver Cancer in Uzbekistan: The Second Report of the Uzbekistan-Korea Oncology Consortium.

Authors:  Chai Hong Rim; Won Jae Lee; Bekhzood Musaev; Ten Yakov Volichevich; Ziyayev Yakhyo Pazlitdinovich; Tillysshaykhov Mirzagaleb Nigmatovich; Jae Suk Rim
Journal:  Int J Environ Res Public Health       Date:  2022-09-17       Impact factor: 4.614
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.